BioSpace Highlights the Northwest's Growing Life Science Region

Print and online campaign celebrates its fifth year

DENVER, Nov. 18, 2010 /PRNewswire/ -- BioSpace launched the 2011 BioForest™ Hotbed Campaign this morning, showcasing biotechnological, pharmaceutical and medical device companies across the United States and Canada.

(Logo: http://photos.prnewswire.com/prnh/20040907/CLTU006LOGO )

(Logo: http://www.newscom.com/cgi-bin/prnh/20040907/CLTU006LOGO )

The campaign promotes life science organizations within Oregon, Washington, Idaho and Montana as well as those in the provinces of Alberta, British Columbia, Manitoba and Saskatchewan. Each campaign participant's logo is added to an electronic and printed map that is featured online and at industry events or career fairs.

"We have nine annual Hotbed campaigns, and they each represent a prominent opportunity for industry businesses to showcase their brand, location and industry presence," said Joe Kroog, BioSpace's Director of Product Management. "However, BioForest is unique because it's one of the only campaigns that highlights Canada's thriving life science region."

Each BioSpace Hotbed campaign is hosted on its own BioSpace Web page. BioForest's participating companies include Gilead Sciences, Inc., Genentech, OncoGenex Pharmaceuticals, Inc., and other leading life science employers.

About BioSpace.com

BioSpace.com is the leading, online resource for industry careers, news and resources. For more than 15 years, BioSpace has helped accelerate recruitment, communication and discovery among business and scientific leaders within the life sciences.

An onTargetjobs, Inc., company, BioSpace powers DeviceSpace.com, an information and recruitment resource for the medical device and diagnostics industries, as well as ClinicaSpace.com, a similar resource for clinical research markets.

SOURCE BioSpace

Suggested Articles

The analysis found Nexvax2 was no better than placebo at protecting patients from gluten, prompting the Arch-backed biotech to stop the study.

Johns Hopkins scientists found that misfolded alpha-synuclein protein can travel from the gut and drive Parkinson's disease.

The financing sets Sanifit up to take its lead drug through phase 3 while exploring its potential in other progressive vascular calcification disorders.